Robert Edwards

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +17

Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus

Nelson B. Watts, John P. Bilezikian, Keith Usiskin et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 449 citations · Full text

Medicine, Pharmacotherapy, Cardiovascular Pharmacotherapy +16

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint et al. · Circulation · 2019 · 288 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

Meg Jardine, Kenneth W. Mahaffey, Bruce Neal et al. · American Journal of Nephrology · 2017 · 241 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

Megumi Oshima, Brendon L. Neuen, Jingwei Li et al. · Journal of the American Society of Nephrology · 2020 · 172 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17